Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
Open Access
- 20 April 2009
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 185 (2) , 279-290
- https://doi.org/10.1083/jcb.200809153
Abstract
It is still unclear whether the BH3-only protein Puma (p53 up-regulated modulator of apoptosis) can prime cells to death and render antiapoptotic BH3-binding Bcl-2 homologues necessary for survival through its ability to directly interact with proapoptotic Bax and activate it. In this study, we provide further evidence, using cell-free assays, that the BH3 domain of Puma binds Bax at an activation site that comprises the first helix of Bax. We also show that, in yeast, Puma interacts with Bax and triggers its killing activity when Bcl-2 homologues are absent but not when Bcl-xL is expressed. Finally, endogenous Puma is involved in the apoptotic response of human colorectal cancer cells to the Bcl-2/Bcl-xL inhibitor ABT-737, even in conditions where the expression of Mcl-1 is down-regulated. Thus, Puma is competent to trigger Bax activity by itself, thereby promoting cellular dependence on prosurvival Bcl-2 family members.Keywords
This publication has 50 references indexed in Scilit:
- BAX activation is initiated at a novel interaction siteNature, 2008
- Contribution of membrane localization to the apoptotic activity of PUMAApoptosis, 2007
- BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteinsThe Journal of cell biology, 2007
- Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1The EMBO Journal, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737Journal of Clinical Investigation, 2007
- FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawalThe Journal of Experimental Medicine, 2006
- Bax does not have to adopt its final form to drive T cell deathThe Journal of Experimental Medicine, 2006
- Mitochondrial Carrier Homolog 2 Is a Target of tBID in Cells Signaled To Die by Tumor Necrosis Factor AlphaMolecular and Cellular Biology, 2005
- Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic ProteinsJournal of Biological Chemistry, 2003